678 related articles for article (PubMed ID: 19577169)
21. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
Yoo SB; Kim YA; Jeon YK; Kim CW
Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
[TBL] [Abstract][Full Text] [Related]
22. Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms.
Challagundla P; Jorgensen JL; Kanagal-Shamanna R; Gurevich I; Pierson DM; Ferrajoli A; Reyes SR; Medeiros LJ; Miranda RN
Arch Pathol Lab Med; 2014 Jul; 138(7):903-9. PubMed ID: 24978916
[TBL] [Abstract][Full Text] [Related]
23. [Salient clinical features of lymphoma and related lymphoproliferative disorders].
Fey MF
Ther Umsch; 2010 Oct; 67(10):491-5. PubMed ID: 20886453
[TBL] [Abstract][Full Text] [Related]
24. [Genetic alterations in malignant lymphoma].
Ohno H
Nihon Rinsho; 2007 Jan; 65 Suppl 1():146-51. PubMed ID: 17474405
[No Abstract] [Full Text] [Related]
25. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
26. Partial nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement analysis in diagnostic work-up.
Gazzola A; Sabattini E; Mannu C; Bacci F; Sagramoso Sacchetti CA; Artioli P; Chilli L; Da Pozzo G; Piccioli M; Falini B; Pileri SA; Piccaluga PP
Pathologica; 2011 Feb; 103(1):14-8. PubMed ID: 21837920
[TBL] [Abstract][Full Text] [Related]
27. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.
Quintanilla-Martinez L; Sander B; Chan JK; Xerri L; Ott G; Campo E; Swerdlow SH
Virchows Arch; 2016 Feb; 468(2):141-57. PubMed ID: 26416032
[TBL] [Abstract][Full Text] [Related]
28. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
[TBL] [Abstract][Full Text] [Related]
29. Systemic CD5+ MALT lymphoma: presentation with Waldenstrom syndrome.
Mikolaenko I; Listinsky CM
Ann Diagn Pathol; 2009 Aug; 13(4):272-7. PubMed ID: 19608087
[TBL] [Abstract][Full Text] [Related]
30. Follicular lymphoma with prominent Dutcher body formation: a pathologic study of 3 cases in comparison with nodal or splenic lymphoplasmacytic lymphoma and marginal zone lymphoma.
Wang E; Stoecker M; Burchette J; Rehder C
Hum Pathol; 2012 Nov; 43(11):2001-11. PubMed ID: 22607703
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetic analysis of haematological malignancies II: Mature lymphoid neoplasms.
Bench AJ; Erber WN; Follows GA; Scott MA
Int J Lab Hematol; 2007 Aug; 29(4):229-60. PubMed ID: 17617076
[TBL] [Abstract][Full Text] [Related]
32. Two for One: B-Cell Lymphomas with Features of Marginal and Follicular Lymphomas.
Glazyrin A; Patel C; Kujtan L; Madhusudhana S
Acta Haematol; 2018; 139(2):84-88. PubMed ID: 29408811
[TBL] [Abstract][Full Text] [Related]
33. Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells.
Bu X; Zheng Z; Wang C; Yu Y
Pathol Res Pract; 2007; 203(3):163-7. PubMed ID: 17307308
[TBL] [Abstract][Full Text] [Related]
34. FISH detection of t(14;18) in follicular lymphoma on Papanicolaou-stained archival cytology slides.
Richmond J; Bryant R; Trotman W; Beatty B; Lunde J
Cancer; 2006 Jun; 108(3):198-204. PubMed ID: 16671111
[TBL] [Abstract][Full Text] [Related]
35. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas.
Akyurek N; Ren Y; Rassidakis GZ; Schlette EJ; Medeiros LJ
Cancer; 2006 Oct; 107(8):1844-51. PubMed ID: 16983704
[TBL] [Abstract][Full Text] [Related]
36. Ocular mantle cell lymphoma with aberrant CD10 expression: a potential diagnostic pitfall.
Lian DW; Chau YP; Lee LK; Teo C; Yap WM; Chuah KL
Pathology; 2009; 41(7):704-6. PubMed ID: 20001358
[No Abstract] [Full Text] [Related]
37. Study of the Utility of Myeloid Cell Nuclear Differentiation Antigen (MNDA) in the Diagnosis of Marginal Zone Lymphoma.
Gupta N; Roychoudry S; Sticco KL; Hsu P; Zhang X; Sheikh-Fayyaz S
Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):217-223. PubMed ID: 36867739
[TBL] [Abstract][Full Text] [Related]
38. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
Juárez-Salcedo LM; Castillo JJ
Hematol Oncol Clin North Am; 2019 Aug; 33(4):639-656. PubMed ID: 31229160
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
Patel N; Durkin L; Bodo J; Hsi ED
Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
[TBL] [Abstract][Full Text] [Related]
40. [Classification and differential diagnosis of B-cell lymphomas].
Anagnostopoulos I
Verh Dtsch Ges Pathol; 2003; 87():32-42. PubMed ID: 16888892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
